Canada Improves Hep C Treatment with Incivek Approval | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

New Hepatitis C Pill in UK

Back to News Homepage
Next

Fast Track for Hep C Drug PSI-938

Canada Improves Hep C Treatment with Incivek Approval

The Editors at Hepatitis Central
August 24, 2011

Print this page

For people new to treatment and those who have failed a previous treatment attempt, Vertex’s Incivek can now be prescribed to Canadians with chronic Hepatitis C.

Vertex Pharma Says Health Canada Okays INCIVEK For People With Hepatitis C
8/22/2011

(RTTNews) – Vertex Pharmaceuticals Inc. (VRTX: News ) Monday said Health Canada has approved INCIVEK, or telaprevir, tablets for people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.

INCIVEK is approved for use in combination with pegylated-interferon and ribavirin, two other medicines approved to treat hepatitis C. It is indicated for people who are new to treatment, and for people who were treated previously but who did not achieve a sustained viral response.

Continue reading this entire article:
http://www.rttnews.com/Content/CanadianNews.aspx?Id=1697262&SM=1

No Comments - be the first!
Share
Share
Previous

New Hepatitis C Pill in UK

Back to News Homepage
Next

Fast Track for Hep C Drug PSI-938

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.